Question 1

Does Glenmede Trust own AXSM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Glenmede Trust holds 942 shares of AXSM (Axsome Therapeutics), worth $230,573.

Question 2

How many shares of AXSM does Glenmede Trust own?

Accepted Answer

As of its Q2 2026 13F, Glenmede Trust holds 942 shares of AXSM (Axsome Therapeutics).

Question 3

What is Glenmede Trust's AXSM position worth?

Accepted Answer

As of its Q2 2026 13F, Glenmede Trust's AXSM position is worth $230,573.

Question 4

Is Glenmede Trust buying or selling AXSM?

Accepted Answer

In Q2 2026, Glenmede Trust reduced its AXSM position by 5,774 shares (-86.0%).

Question 5

When did Glenmede Trust first buy AXSM?

Accepted Answer

Glenmede Trust first reported AXSM in its Q2 2019 13F and has listed it in 25 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	942	-86.0%	$230,573	0.0%	$244.77	0
2026-Q1	Decreased	6,716	-3.0%	$1.1M	0.0%	$169.02	0
2025-Q4	Decreased	6,924	-9.0%	$1.3M	0.0%	$182.64	0
2025-Q1	Increased	7,607	+39.2%	$887,204	0.0%	$116.63	33
2024-Q4	Decreased	5,466	-26.9%	$462,478	0.0%	$84.61	0
2024-Q3	Increased	7,473	+0.9%	$671,598	0.0%	$89.87	25